Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
After-Hours: 20:00
Collegium Pharmaceutical Free Cash Flow: 192.43M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 192.43M |
| June 30, 2024 | 275.62M |
| March 31, 2024 | 308.16M |
| December 31, 2023 | 274.29M |
| September 30, 2023 | 266.50M |
| June 30, 2023 | 235.20M |
| March 31, 2023 | 175.53M |
| December 31, 2022 | 122.61M |
| September 30, 2022 | 92.91M |
| June 30, 2022 | 67.23M |
| March 31, 2022 | 56.05M |
| December 31, 2021 | 101.61M |
| September 30, 2021 | 87.03M |
| June 30, 2021 | 101.82M |
| March 31, 2021 | 114.63M |
| December 31, 2020 | -279.83M |
| September 30, 2020 | -286.16M |
| June 30, 2020 | -313.22M |
| March 31, 2020 | -341.08M |
| December 31, 2019 | 21.34M |
| Date | Value |
|---|---|
| September 30, 2019 | 47.09M |
| June 30, 2019 | 81.49M |
| March 31, 2019 | 122.60M |
| December 31, 2018 | 145.04M |
| September 30, 2018 | 91.05M |
| June 30, 2018 | 39.03M |
| March 31, 2018 | -33.74M |
| December 31, 2017 | -68.01M |
| September 30, 2017 | -78.17M |
| June 30, 2017 | -84.79M |
| March 31, 2017 | -90.23M |
| December 31, 2016 | -78.03M |
| September 30, 2016 | -63.53M |
| June 30, 2016 | -50.69M |
| March 31, 2016 | -31.76M |
| December 31, 2015 | -21.57M |
| September 30, 2015 | -20.20M |
| June 30, 2015 | -18.07M |
| March 31, 2015 | -15.86M |
| December 31, 2014 | -17.95M |
Free Cash Flow Range, Past 5 Years
-341.08M
Minimum
Mar 2020
308.16M
Maximum
Mar 2024
63.63M
Average
101.72M
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics Inc | -31.51M |
| Insmed Inc | -636.03M |
| Pulmonx Corp | -34.79M |
| RxSight Inc | -27.17M |
| Context Therapeutics Inc | -31.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.999M |
| Cash from Investing (Quarterly) | -248.96M |
| Cash from Financing (Quarterly) | 149.03M |
| Free Cash Flow Per Share (Quarterly) | -0.2301 |
| Free Cash Flow to Equity (Quarterly) | -323.62M |
| Free Cash Flow to Firm (Quarterly) | -0.1872M |
| Free Cash Flow Yield | 13.99% |